Rigel Pharmaceuticals (RIGL) Return on Invested Capital (2024 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Return on Invested Capital of 0.04% for Q1 2026, up 2.0% year-over-year from 0.03% in Q1 2025, and down 19.32% quarter-over-quarter from 0.04% in Q4 2025.
Rigel Pharmaceuticals (RIGL) Return on Invested Capital (2024 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Return on Invested Capital history runs 3 years deep, the most recent figure standing at 0.04% for Q1 2026.
- In Q1 2026, Return on Invested Capital rose 2.0% year-over-year to 0.04%; the TTM figure through Mar 2026 stood at 0.04% (up 2.0% YoY), while the FY2025 annual figure was 0.2%, up 17.0% from the prior year.
- Return on Invested Capital for Q1 2026 stood at 0.04%, down from 0.04% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.04% in Q4 2025, with the low at 0.01% in Q4 2024.
- The 3-year median for Return on Invested Capital is 0.03% (2025), against an average of 0.03%.
- The sharpest annual moves came in 2025 and 2026: Return on Invested Capital grew 3 bps in 2025, then rose 2 bps in 2026.
- Rigel Pharmaceuticals' Return on Invested Capital stood at 0.01% in 2024, then jumped by 323 bps to 0.04% in 2025, then declined by 19 bps to 0.04% in 2026.
- Business Quant data shows RIGL's Return on Invested Capital at 0.04% in Q1 2026, 0.04% in Q4 2025, and 0.02% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.05% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.35% |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | 0.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.03% |
| Mar 31, 2026 | 0.04% |
| Dec 31, 2025 | 0.04% |
| Sep 30, 2025 | 0.02% |
| Jun 30, 2025 | 0.03% |
| Mar 31, 2025 | 0.02% |
| Dec 31, 2024 | 0.01% |